世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

口蹄疫ワクチンの世界市場 2021-2025年


Global Foot and Mouth Disease Vaccines Market 2021-2025

口蹄疫ワクチンの世界市場 2021-2025年 Technavio社は口蹄疫ワクチン市場をモニターしており、予測期間中に8.81%のCAGRで進行し、2021年から2025年にかけて10.8億ドルの成長が見込まれています。当レポートでは... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2021年8月13日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

口蹄疫ワクチンの世界市場 2021-2025年
Technavio社は口蹄疫ワクチン市場をモニターしており、予測期間中に8.81%のCAGRで進行し、2021年から2025年にかけて10.8億ドルの成長が見込まれています。当レポートでは、口蹄疫ワクチン市場について、全体的な分析、市場規模と予測、動向、成長要因、課題のほか、約25社のベンダーを対象としたベンダー分析も行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、政府の取り組みの増加と、アジアや中東で頻発するFMDの発生です。さらに、政府の取り組みの増加は、市場の成長を後押しすると予想されます。
口蹄疫ワクチン市場の分析では、製品セグメントと地域別の状況が示されています。
Technavioの口蹄疫ワクチン市場は以下のように区分されています。
製品別
- 従来型ワクチン
- 緊急用ワクチン
地理的ランドスケープ別
- アジア
- 欧州
- 北アメリカ
- ROW
本調査では、畜産物に対する需要の増加が、今後数年間の口蹄疫ワクチン市場の成長を促進する主な理由の一つであるとしています。
Technavio社は、複数の情報源から得たデータを主要なパラメータの分析によって調査、合成、要約することで、市場の詳細な状況を示しています。当レポートでは、口蹄疫ワクチン市場について、以下の項目を取り上げています。
- 口蹄疫ワクチンの市場サイジング
- 口腔疾患用ワクチン市場の予測
- 口蹄疫ワクチン市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としています。これに沿って、本レポートでは、口蹄疫ワクチン市場の主要ベンダーであるBiogenesis Bago SA、Boehringer Ingelheim International GmbH、Ceva Sante Animale、Indian Immunologicals Ltd.、Inovio Pharmaceuticals Inc.、Merck & Co.Inc.、SEPPIC SA、VECOL SA、VETAL Animal Health Products Inc.などがあります。また、口蹄疫ワクチン市場分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からの情報を含む、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/foot-and-mouth-disease-vaccines-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的および量的調査を用いた詳細なベンダー選択方法および分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Conventional vaccines - Market size and forecast 2020-2025
o Emergency vaccines - Market size and forecast 2020-2025
o Market opportunity by Product
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Asia - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o North America - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Biogenesis Bago SA
o Boehringer Ingelheim International GmbH
o Ceva Sante Animale
o Indian Immunologicals Ltd.
o Inovio Pharmaceuticals Inc.
o Merck & Co. Inc.
o SEPPIC SA
o VECOL SA
o VETAL Animal Health Products Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Conventional vaccines - Market size and forecast 2020-2025 ($ million)
• 24: Conventional vaccines - Year-over-year growth 2020-2025 (%)
• 25: Emergency vaccines - Market size and forecast 2020-2025 ($ million)
• 26: Emergency vaccines - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: Asia - Market size and forecast 2020-2025 ($ million)
• 32: Asia - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: North America - Market size and forecast 2020-2025 ($ million)
• 36: North America - Year-over-year growth 2020-2025 (%)
• 37: ROW - Market size and forecast 2020-2025 ($ million)
• 38: ROW - Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Biogenesis Bago SA - Overview
• 48: Biogenesis Bago SA - Product and service
• 49: Biogenesis Bago SA - Key offerings
• 50: Biogenesis Bago SA - Key customers
• 51: Biogenesis Bago SA - Segment focus
• 52: Boehringer Ingelheim International GmbH - Overview
• 53: Boehringer Ingelheim International GmbH - Business segments
• 54: Boehringer Ingelheim International GmbH - Key offerings
• 55: Boehringer Ingelheim International GmbH - Key customers
• 56: Boehringer Ingelheim International GmbH - Segment focus
• 57: Ceva Sante Animale - Overview
• 58: Ceva Sante Animale - Product and service
• 59: Ceva Sante Animale - Key offerings
• 60: Ceva Sante Animale - Key customers
• 61: Ceva Sante Animale - Segment focus
• 62: Indian Immunologicals Ltd. - Overview
• 63: Indian Immunologicals Ltd. - Product and service
• 64: Indian Immunologicals Ltd. - Key offerings
• 65: Indian Immunologicals Ltd. - Key customers
• 66: Indian Immunologicals Ltd. - Segment focus
• 67: Inovio Pharmaceuticals Inc. - Overview
• 68: Inovio Pharmaceuticals Inc. - Product and service
• 69: Inovio Pharmaceuticals Inc. - Key offerings
• 70: Inovio Pharmaceuticals Inc. - Key customers
• 71: Inovio Pharmaceuticals Inc. - Segment focus
• 72: Merck & Co. Inc. - Overview
• 73: Merck & Co. Inc. - Business segments
• 74: Merck & Co. Inc. - Key offerings
• 75: Merck & Co. Inc. - Key customers
• 76: Merck & Co. Inc. - Segment focus
• 77: SEPPIC SA - Overview
• 78: SEPPIC SA - Product and service
• 79: SEPPIC SA - Key offerings
• 80: SEPPIC SA - Key customers
• 81: SEPPIC SA - Segment focus
• 82: VECOL SA - Overview
• 83: VECOL SA - Product and service
• 84: VECOL SA - Key offerings
• 85: VECOL SA - Key customers
• 86: VECOL SA - Segment focus
• 87: VETAL Animal Health Products Inc. - Overview
• 88: VETAL Animal Health Products Inc. - Product and service
• 89: VETAL Animal Health Products Inc. - Key offerings
• 90: VETAL Animal Health Products Inc. - Key customers
• 91: VETAL Animal Health Products Inc. - Segment focus
• 92: Currency conversion rates for US$
• 93: Research Methodology
• 94: Validation techniques employed for market sizing
• 95: Information sources
• 96: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Foot and Mouth Disease Vaccines Market 2021-2025
Technavio has been monitoring the foot and mouth disease vaccines market and it is poised to grow by $ 1.08 bn during 2021-2025, progressing at a CAGR of 8.81% during the forecast period. Our report on the foot and mouth disease vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in government initiatives and frequent FMD outbreaks in Asia and the Middle East. In addition, increase in government initiatives is anticipated to boost the growth of the market as well.
The foot and mouth disease vaccines market analysis includes the product segment and geographic landscape.
Technavio's foot and mouth disease vaccines market is segmented as below:
By Product
• Conventional vaccines
• Emergency vaccines
By Geographical Landscape
• Asia
• Europe
• North America
• ROW
This study identifies the increase in demand for livestock productsas one of the prime reasons driving the foot and mouth disease vaccines market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on foot and mouth disease vaccines market covers the following areas:
• Foot and mouth disease vaccines market sizing
• Foot and mouth disease vaccines market forecast
• Foot and mouth disease vaccines market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading foot and mouth disease vaccines market vendors that include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc. Also, the foot and mouth disease vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/foot-and-mouth-disease-vaccines-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Conventional vaccines - Market size and forecast 2020-2025
o Emergency vaccines - Market size and forecast 2020-2025
o Market opportunity by Product
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Asia - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o North America - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Biogenesis Bago SA
o Boehringer Ingelheim International GmbH
o Ceva Sante Animale
o Indian Immunologicals Ltd.
o Inovio Pharmaceuticals Inc.
o Merck & Co. Inc.
o SEPPIC SA
o VECOL SA
o VETAL Animal Health Products Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Conventional vaccines - Market size and forecast 2020-2025 ($ million)
• 24: Conventional vaccines - Year-over-year growth 2020-2025 (%)
• 25: Emergency vaccines - Market size and forecast 2020-2025 ($ million)
• 26: Emergency vaccines - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: Asia - Market size and forecast 2020-2025 ($ million)
• 32: Asia - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: North America - Market size and forecast 2020-2025 ($ million)
• 36: North America - Year-over-year growth 2020-2025 (%)
• 37: ROW - Market size and forecast 2020-2025 ($ million)
• 38: ROW - Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Biogenesis Bago SA - Overview
• 48: Biogenesis Bago SA - Product and service
• 49: Biogenesis Bago SA - Key offerings
• 50: Biogenesis Bago SA - Key customers
• 51: Biogenesis Bago SA - Segment focus
• 52: Boehringer Ingelheim International GmbH - Overview
• 53: Boehringer Ingelheim International GmbH - Business segments
• 54: Boehringer Ingelheim International GmbH - Key offerings
• 55: Boehringer Ingelheim International GmbH - Key customers
• 56: Boehringer Ingelheim International GmbH - Segment focus
• 57: Ceva Sante Animale - Overview
• 58: Ceva Sante Animale - Product and service
• 59: Ceva Sante Animale - Key offerings
• 60: Ceva Sante Animale - Key customers
• 61: Ceva Sante Animale - Segment focus
• 62: Indian Immunologicals Ltd. - Overview
• 63: Indian Immunologicals Ltd. - Product and service
• 64: Indian Immunologicals Ltd. - Key offerings
• 65: Indian Immunologicals Ltd. - Key customers
• 66: Indian Immunologicals Ltd. - Segment focus
• 67: Inovio Pharmaceuticals Inc. - Overview
• 68: Inovio Pharmaceuticals Inc. - Product and service
• 69: Inovio Pharmaceuticals Inc. - Key offerings
• 70: Inovio Pharmaceuticals Inc. - Key customers
• 71: Inovio Pharmaceuticals Inc. - Segment focus
• 72: Merck & Co. Inc. - Overview
• 73: Merck & Co. Inc. - Business segments
• 74: Merck & Co. Inc. - Key offerings
• 75: Merck & Co. Inc. - Key customers
• 76: Merck & Co. Inc. - Segment focus
• 77: SEPPIC SA - Overview
• 78: SEPPIC SA - Product and service
• 79: SEPPIC SA - Key offerings
• 80: SEPPIC SA - Key customers
• 81: SEPPIC SA - Segment focus
• 82: VECOL SA - Overview
• 83: VECOL SA - Product and service
• 84: VECOL SA - Key offerings
• 85: VECOL SA - Key customers
• 86: VECOL SA - Segment focus
• 87: VETAL Animal Health Products Inc. - Overview
• 88: VETAL Animal Health Products Inc. - Product and service
• 89: VETAL Animal Health Products Inc. - Key offerings
• 90: VETAL Animal Health Products Inc. - Key customers
• 91: VETAL Animal Health Products Inc. - Segment focus
• 92: Currency conversion rates for US$
• 93: Research Methodology
• 94: Validation techniques employed for market sizing
• 95: Information sources
• 96: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(抗生物薬)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る